It's that time of year again: students and their families are busy preparing for the start of school, while some of us are gearing up to step in front of the classroom. While preparing to teach an ...
Increased exposure to commercial insights could help the UK military better guide investment in AI for battlefield use. Navigating the AI Landscape: Lessons from the Gartner Hype Cycle for Military ...
That is one of the main takeaways in UEFA's latest European Club Talent and Competition Landscape report, looking at current trends in European football, which has just been published. One of two ...
Goldman Sachs notes that although the Phase 3 efficacy data for rocatinlimab is less compelling compared to Dupixent, the analyst still sees strong commercial potential for the drug (if approved).